D61.1 – Drug-induced aplastic anemia

ICD-10-CM 2027 diagnosis code · Aplastic and other anemias and other bone marrow failure syndromes

Billable code

ICD-10-CM code D61.1

Code: D61.1 (claims format: D611)
Description: Drug-induced aplastic anemia
Billable: Yes – valid for HIPAA-covered transactions
Valid for: Dates of service October 1, 2026 – September 30, 2027 (FY2027)
Chapter: 3. Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Block: D60-D64 Aplastic and other anemias and other bone marrow failure syndromes
Parent codes: D61

Notes for D61.1

Use additional code:

code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Notes inherited from parent codes

Instructional notes at a category or block level apply to every code below it.

D61 – Other aplastic anemias and other bone marrow failure syndromes

Excludes2 (not included here):

neutropenia (D70.-)

Index terms for D61.1

Entries in the ICD-10-CM alphabetic index that lead to this code:

Related codes in D61

Frequently asked questions

What is ICD-10 code D61.1?

D61.1 is the ICD-10-CM code for drug-induced aplastic anemia, in the block D60-D64 (Aplastic and other anemias and other bone marrow failure syndromes).

Is D61.1 a billable code?

Yes. D61.1 is a billable/specific code that can be used to indicate a diagnosis for reimbursement purposes.

What category does D61.1 belong to?

It belongs to category D61 – Other aplastic anemias and other bone marrow failure syndromes.

Source: CDC/NCHS ICD-10-CM FY2027 code files, tabular list and index. Reference only – code assignment must follow the official ICD-10-CM guidelines and documentation in the medical record.